| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.24 | 5e-06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-06 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |